ID   KCNC1_RAT               Reviewed;         585 AA.
AC   P25122;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   02-OCT-2024, entry version 181.
DE   RecName: Full=Voltage-gated potassium channel KCNC1 {ECO:0000305};
DE   AltName: Full=NGK2 {ECO:0000250|UniProtKB:P48547};
DE   AltName: Full=Potassium voltage-gated channel subfamily C member 1;
DE   AltName: Full=RAW2;
DE   AltName: Full=Voltage-gated potassium channel subunit Kv3.1 {ECO:0000305|PubMed:10482766};
DE   AltName: Full=Voltage-gated potassium channel subunit Kv4 {ECO:0000250|UniProtKB:P48547};
GN   Name=Kcnc1 {ECO:0000312|RGD:2955};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TRANSPORTER ACTIVITY.
RX   PubMed=2023941; DOI=10.1073/pnas.88.9.3932;
RA   Luneau C.J., Williams J.B., Marshall J., Levitan E.S., Oliva C.,
RA   Smith J.S., Antanavage J., Folander K., Stein R.B., Swanson R.,
RA   Kaczmarek L.K., Buhrow S.A.;
RT   "Alternative splicing contributes to K+ channel diversity in the mammalian
RT   central nervous system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3932-3936(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=1378392; DOI=10.1002/j.1460-2075.1992.tb05312.x;
RA   Rettig J., Wunder F., Stocker M., Lichtinghagen R., Mastiaux F., Beckh S.,
RA   Kues W., Pedarzani P., Schroeter K.H., Ruppersberg J.P., Veh R., Pongs O.;
RT   "Characterization of a Shaw-related potassium channel family in rat
RT   brain.";
RL   EMBO J. 11:2473-2486(1992).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBUNIT, INTERACTION WITH KCNC2,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=10482766; DOI=10.1152/jn.1999.82.3.1512;
RA   Hernandez-Pineda R., Chow A., Amarillo Y., Moreno H., Saganich M.,
RA   Vega-Saenz de Miera E.C., Hernandez-Cruz A., Rudy B.;
RT   "Kv3.1-Kv3.2 channels underlie a high-voltage-activating component of the
RT   delayed rectifier K+ current in projecting neurons from the globus
RT   pallidus.";
RL   J. Neurophysiol. 82:1512-1528(1999).
RN   [4]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBUNIT, INTERACTION WITH KCNC2; KCNE1 AND
RP   KCNE2, AND SUBCELLULAR LOCATION.
RX   PubMed=14679187; DOI=10.1074/jbc.m310501200;
RA   Lewis A., McCrossan Z.A., Abbott G.W.;
RT   "MinK, MiRP1, and MiRP2 diversify Kv3.1 and Kv3.2 potassium channel
RT   gating.";
RL   J. Biol. Chem. 279:7884-7892(2004).
RN   [5]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=20857303; DOI=10.1007/s00418-010-0742-6;
RA   Puente N., Mendizabal-Zubiaga J., Elezgarai I., Reguero L., Buceta I.,
RA   Grandes P.;
RT   "Precise localization of the voltage-gated potassium channel subunits
RT   Kv3.1b and Kv3.3 revealed in the molecular layer of the rat cerebellar
RT   cortex by a pre-embedding immunogold method.";
RL   Histochem. Cell Biol. 134:403-409(2010).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; SER-130; SER-142; SER-158
RP   AND SER-160, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   SUBCELLULAR LOCATION, GLYCOSYLATION AT ASN-220 AND ASN-229, AND MUTAGENESIS
RP   OF ASN-220 AND ASN-229.
RX   PubMed=24161696; DOI=10.1016/j.bbagen.2013.10.025;
RA   Hall M.K., Weidner D.A., Bernetski C.J., Schwalbe R.A.;
RT   "N-Linked glycan site occupancy impacts the distribution of a potassium
RT   channel in the cell body and outgrowths of neuronal-derived cells.";
RL   Biochim. Biophys. Acta 1840:595-604(2014).
CC   -!- FUNCTION: Voltage-gated potassium channel that opens in response to the
CC       voltage difference across the membrane and through which potassium ions
CC       pass in accordance with their electrochemical gradient (Probable)
CC       (PubMed:10482766, PubMed:1378392, PubMed:14679187). The mechanism is
CC       time-dependent and inactivation is slow (PubMed:10482766,
CC       PubMed:1378392). Plays an important role in the rapid repolarization of
CC       fast-firing brain neurons (PubMed:10482766). Can form functional
CC       homotetrameric channels and heterotetrameric channels that contain
CC       variable proportions of KCNC2, and possibly other family members as
CC       well (PubMed:10482766, PubMed:14679187). Contributes to fire sustained
CC       trains of very brief action potentials at high frequency in pallidal
CC       neurons (PubMed:10482766). {ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:1378392, ECO:0000269|PubMed:14679187,
CC       ECO:0000305|PubMed:2023941}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:1378392,
CC         ECO:0000269|PubMed:14679187, ECO:0000305|PubMed:2023941};
CC   -!- SUBUNIT: Homotetramer. Homomultimer (By similarity). Heteromultimer
CC       with KCNG3, KCNG4 and KCNV2 (By similarity). Heteromultimer with KCNC2
CC       (PubMed:10482766, PubMed:14679187). Heterotetramer with KCNC3 (By
CC       similarity). Interacts with the ancillary subunits KCNE1 and KCNE2; the
CC       interaction modulates channel activity (PubMed:14679187). {ECO:0000250,
CC       ECO:0000250|UniProtKB:P48547, ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:14679187}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10482766,
CC       ECO:0000269|PubMed:14679187, ECO:0000269|PubMed:24161696}; Multi-pass
CC       membrane protein {ECO:0000255}. Cell projection, axon
CC       {ECO:0000269|PubMed:20857303}. Presynaptic cell membrane
CC       {ECO:0000269|PubMed:20857303}. Note=Localizes in parallel fiber
CC       membranes, distributed on the perisynaptic and extrasynaptic membranes
CC       away from the active zones. {ECO:0000269|PubMed:20857303}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P25122-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=P25122-2; Sequence=VSP_001016, VSP_001017;
CC   -!- TISSUE SPECIFICITY: Expressed in brain (PubMed:1378392). Expressed in
CC       globus pallidal neurons of the basal ganglia (at protein level)
CC       (PubMed:10482766). Detected on Purkinje cells in the cerebellum
CC       molecular layer (at protein level) (PubMed:20857303).
CC       {ECO:0000269|PubMed:10482766, ECO:0000269|PubMed:1378392,
CC       ECO:0000269|PubMed:20857303}.
CC   -!- DOMAIN: The segment S4 is probably the voltage-sensor and is
CC       characterized by a series of positively charged amino acids at every
CC       third position. {ECO:0000305}.
CC   -!- DOMAIN: The N-terminal cytoplasmic T1 domain is involved but not
CC       required for Zn(2+)-mediated tetramerization.
CC       {ECO:0000250|UniProtKB:P48547}.
CC   -!- PTM: N-glycosylated; contains sialylated glycans.
CC       {ECO:0000269|PubMed:24161696}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. C (Shaw) (TC
CC       1.A.1.2) subfamily. Kv3.1/KCNC1 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M68880; AAA41501.1; -; mRNA.
DR   EMBL; X62840; CAA44644.1; -; mRNA.
DR   PIR; A39395; A39395.
DR   RefSeq; NP_036988.1; NM_012856.1. [P25122-1]
DR   AlphaFoldDB; P25122; -.
DR   SMR; P25122; -.
DR   BioGRID; 247366; 1.
DR   STRING; 10116.ENSRNOP00000074146; -.
DR   BindingDB; P25122; -.
DR   ChEMBL; CHEMBL2321617; -.
DR   DrugCentral; P25122; -.
DR   GuidetoPHARMACOLOGY; 548; -.
DR   GlyCosmos; P25122; 2 sites, No reported glycans.
DR   GlyGen; P25122; 2 sites.
DR   iPTMnet; P25122; -.
DR   PhosphoSitePlus; P25122; -.
DR   PaxDb; 10116-ENSRNOP00000015260; -.
DR   ABCD; P25122; 1 sequenced antibody.
DR   Ensembl; ENSRNOT00000089488.2; ENSRNOP00000074146.1; ENSRNOG00000055401.2. [P25122-1]
DR   Ensembl; ENSRNOT00055011242; ENSRNOP00055008815; ENSRNOG00055006842. [P25122-1]
DR   Ensembl; ENSRNOT00060019032; ENSRNOP00060014855; ENSRNOG00060011256. [P25122-1]
DR   Ensembl; ENSRNOT00065013925; ENSRNOP00065010370; ENSRNOG00065008751. [P25122-1]
DR   GeneID; 25327; -.
DR   KEGG; rno:25327; -.
DR   UCSC; RGD:2955; rat. [P25122-1]
DR   AGR; RGD:2955; -.
DR   CTD; 3746; -.
DR   RGD; 2955; Kcnc1.
DR   eggNOG; KOG3713; Eukaryota.
DR   GeneTree; ENSGT00940000156912; -.
DR   HOGENOM; CLU_011722_4_3_1; -.
DR   InParanoid; P25122; -.
DR   OMA; EIVGNDT; -.
DR   OrthoDB; 1478695at2759; -.
DR   PhylomeDB; P25122; -.
DR   Reactome; R-RNO-1296072; Voltage gated Potassium channels.
DR   PRO; PR:P25122; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000055401; Expressed in cerebellum and 7 other cell types or tissues.
DR   GO; GO:0030673; C:axolemma; ISO:RGD.
DR   GO; GO:0043679; C:axon terminus; IBA:GO_Central.
DR   GO; GO:0044305; C:calyx of Held; IDA:SynGO.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0032590; C:dendrite membrane; ISO:RGD.
DR   GO; GO:0032589; C:neuron projection membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0032809; C:neuronal cell body membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; IDA:UniProtKB.
DR   GO; GO:0005251; F:delayed rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0019894; F:kinesin binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044325; F:transmembrane transporter binding; IPI:UniProtKB.
DR   GO; GO:0099508; F:voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; ISS:UniProtKB.
DR   GO; GO:0001508; P:action potential; IBA:GO_Central.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0021549; P:cerebellum development; IEP:RGD.
DR   GO; GO:0022038; P:corpus callosum development; IEP:RGD.
DR   GO; GO:0021759; P:globus pallidus development; IEP:RGD.
DR   GO; GO:0021554; P:optic nerve development; IEP:RGD.
DR   GO; GO:0034767; P:positive regulation of monoatomic ion transmembrane transport; IDA:RGD.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IEA:InterPro.
DR   GO; GO:0051262; P:protein tetramerization; ISS:UniProtKB.
DR   GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; IMP:RGD.
DR   GO; GO:1901379; P:regulation of potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0010996; P:response to auditory stimulus; IEP:RGD.
DR   GO; GO:0071774; P:response to fibroblast growth factor; IEP:RGD.
DR   GO; GO:0009642; P:response to light intensity; IEP:RGD.
DR   GO; GO:1990089; P:response to nerve growth factor; IEP:RGD.
DR   GO; GO:0035864; P:response to potassium ion; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   CDD; cd18414; BTB_KCNC1_3; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003968; K_chnl_volt-dep_Kv.
DR   InterPro; IPR003974; K_chnl_volt-dep_Kv3.
DR   InterPro; IPR005403; K_chnl_volt-dep_Kv3.1.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR003131; T1-type_BTB.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR11537:SF87; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY C MEMBER 1; 1.
DR   PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02214; BTB_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR00169; KCHANNEL.
DR   PRINTS; PR01581; KV31CHANNEL.
DR   PRINTS; PR01491; KVCHANNEL.
DR   PRINTS; PR01498; SHAWCHANNEL.
DR   SMART; SM00225; BTB; 1.
DR   SUPFAM; SSF54695; POZ domain; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cell projection; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Phosphoprotein;
KW   Potassium; Potassium channel; Potassium transport; Reference proteome;
KW   Synapse; Transmembrane; Transmembrane helix; Transport;
KW   Voltage-gated channel; Zinc.
FT   CHAIN           1..585
FT                   /note="Voltage-gated potassium channel KCNC1"
FT                   /id="PRO_0000054053"
FT   TOPO_DOM        1..190
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        191..209
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        248..267
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        268..276
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        277..295
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        309..331
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        332..344
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        345..366
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        415..436
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        437..585
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          121..147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           400..405
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250"
FT   BINDING         77
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         83
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         104
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         105
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         400
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         401
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         402
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   BINDING         403
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="ligand shared between homotetrameric
FT                   partners"
FT                   /evidence="ECO:0000250|UniProtKB:P48547"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         158
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         474
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15388"
FT   MOD_RES         483
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P15388"
FT   CARBOHYD        220
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:24161696"
FT   CARBOHYD        229
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:24161696"
FT   VAR_SEQ         502..511
FT                   /note="DSKLNGEVAK -> GRKPLRGMSI (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001016"
FT   VAR_SEQ         512..585
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001017"
FT   MUTAGEN         220
FT                   /note="N->Q: Reduces extent of N-glycosylation. Abolishes
FT                   N-glycosylation; when associated with Q-229."
FT                   /evidence="ECO:0000269|PubMed:24161696"
FT   MUTAGEN         229
FT                   /note="N->Q: Reduces extent of N-glycosylation. Abolishes
FT                   N-glycosylation; when associated with Q-220."
FT                   /evidence="ECO:0000269|PubMed:24161696"
SQ   SEQUENCE   585 AA;  65857 MW;  DD4E2D32848E2DCF CRC64;
     MGQGDESERI VINVGGTRHQ TYRSTLRTLP GTRLAWLAEP DAHSHFDYDP RADEFFFDRH
     PGVFAHILNY YRTGKLHCPA DVCGPLYEEE LAFWGIDETD VEPCCWMTYR QHRDAEEALD
     SFGGAPLDNS ADDADADGPG DSGDGEDELE MTKRLALSDS PDGRPGGFWR RWQPRIWALF
     EDPYSSRYAR YVAFASLFFI LVSITTFCLE THERFNPIVN KTEIENVRNG TQVRYYREAE
     TEAFLTYIEG VCVVWFTFEF LMRVVFCPNK VEFIKNSLNI IDFVAILPFY LEVGLSGLSS
     KAAKDVLGFL RVVRFVRILR IFKLTRHFVG LRVLGHTLRA STNEFLLLII FLALGVLIFA
     TMIYYAERIG AQPNDPSASE HTHFKNIPIG FWWAVVTMTT LGYGDMYPQT WSGMLVGALC
     ALAGVLTIAM PVPVIVNNFG MYYSLAMAKQ KLPKKKKKHI PRPPQLGSPN YCKSVVNSPH
     HSTQSDTCPL AQEEILEINR ADSKLNGEVA KAALANEDCP HIDQALTPDE GLPFTRSGTR
     ERYGPCFLLS TGEYACPPGG GMRKDLCKES PVIAKYMPTE AVRVT
//
